Login to Your Account


Friday, January 12, 2018

Braeburn Pharmaceuticals Inc., of Princeton, N.J., said it completed a $110 million mezzanine round of financing led by Wellington Capital Management.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription